Nov 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.98 6.65 15.20
(-30.2 pct)
Operating loss 568 mln loss 320 mln 670 mln
Recurring loss 568 mln loss 319 mln 670 mln
Net loss 464 mln loss 201 mln 540 mln
EPS loss 122.83 yen loss 53.38 yen 142.80 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T